World
CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Boehringer Ingelheim launches expanded access for Tipranavir
Drugmaker Boehringer Ingelheim on Tuesday announced the launch of an expanded access program for its experimental protease inhibitor Tipranavir. The program provides access to the drug for all treatment-experienced HIV patients not enrolled in the ongoing clinical study of Tipranavir who have demonstrated resistance to other protease inhibitors. Eligibility for the program is not limited by CD4-cell counts or HIV viral loads. Tipranavir is currently in Phase III studies and was submitted to the Food and Drug Administration for marketing approval in late October. A decision by the FDA is expected by April. Tipranavir is a nonpeptidic drug, unlike other protease inhibitors, giving it a unique resistance profile and making it effective for most HIV patients resistant to other protease drugs. For more information about the expanded access program, health care providers can call (888) 524-8675 or go online to www.tpv-eap.com.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Lauren Boebert Caught Fondling Date’s Genitals During Family-Friendly Musical: Video
September 15 2023 11:20 PM
Don’t miss our latest news! Sign up today for our free newsletter.
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Halloween New Orleans Is Throwing an XL-Sized Party, Celebrating 40 Years of AIDS Fundraising
September 25 2023 6:17 PM
Pete Buttigieg Slams Donald Trump’s Alleged Remarks About Disabled Veterans
September 25 2023 4:37 PM
Tennessee’s First Transgender Elected Official, Olivia Hill, May Have to Use Men's Restroom
September 25 2023 1:00 PM
Gavin Newsom Vetoes Bill Requiring Custody Decisions Involve Affirming Children’s Gender Identity
September 25 2023 10:00 AM
There's Been a 33% Increase In Book Bans Across the U.S., Says PEN America
September 25 2023 8:00 AM